524 related articles for article (PubMed ID: 35960736)
1. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
[TBL] [Abstract][Full Text] [Related]
3. Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia.
Alharbi NK; Alghnam S; Algaissi A; Albalawi H; Alenazi MW; Albargawi AM; Alharbi AG; Alhazmi A; Al Qarni A; Alfarhan A; Zowawi HM; Alhatmi H; Alghamdi J; Alroqi F; Batarfi K; Arabi YM; Hashem AM; Bosaeed M; Aldibasi O
J Infect Public Health; 2021 Jul; 14(7):832-838. PubMed ID: 34118732
[TBL] [Abstract][Full Text] [Related]
4. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence, correlates and kinetics of SARS-CoV-2 nucleocapsid IgG antibody in healthcare workers and nonclinical staff at a tertiary hospital: A prevaccine census study.
Maina D; Omuse G; Ong'ete G; Mugaine P; Sayed S; Moloo Z; Shah R; Etyang A; Adam R
PLoS One; 2022; 17(10):e0267619. PubMed ID: 36301926
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and predictors that influence SARS-Cov-2 IgG positivity: A cross-sectional study of blood donors in Riyadh, Saudi Arabia.
Alosaimi MF; Alhetheel A; Aleisa KA; Altwerki AA; Alenezy NM; Almutairi EM; Alothaim LO; Khalid AMA; Alayed KM; Almazyad MA; BinMoammar TA; Alshobaili FA; Al-Shahrani FS; Alsubaie S; Hasanato RM
Saudi Med J; 2021 Aug; 42(8):853-861. PubMed ID: 34344809
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
Front Public Health; 2022; 10():832003. PubMed ID: 35400056
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
[TBL] [Abstract][Full Text] [Related]
9. Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study.
Mehboob S; Rehman A; Haq M; Rajab H; Haq M; Haq H; Ahmad J; Ahmad S; Abbas M; Anwar S; Haq N
Ir J Med Sci; 2023 Apr; 192(2):915-918. PubMed ID: 35412213
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.
Recanatini C; GeurtsvanKessel CH; Pas SD; Broens EM; Maas M; van Mansfeld R; Mutsaers-van Oudheusden AJG; van Rijen M; Schippers EF; Stegeman A; Tami A; Veldkamp KE; Visser H; Voss A; Wegdam-Blans MCA; Wertheim HFL; Wever PC; Koopmans MPG; Kluytmans JAJW; Kluytmans-van den Bergh MFQ;
Antimicrob Resist Infect Control; 2023 Nov; 12(1):137. PubMed ID: 38031155
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia.
Alhabbab RY; Alsaieedi A; Algaissi A; Almahboub S; Al-Raddadi RM; Shabouni OI; Alhabbab R; Alfaraj AA; Alamri SS; Aljehani ND; Abdulal RH; Alfaleh MA; Abujamel TS; Alkayyal AA; Mahmoud AB; Abuzenadah AM; Hashem AM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372618
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.
Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M
BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 seroprevalence among healthcare workers from a tertiary care center in Riyadh, Saudi Arabia.
Albaadani AM; Alsufyani EA; Mursi MI; Haris MH; Kalam KK; Alsherbeeni NM; Al-Rumaihi AM; Alateah SM; Ahmed MA; Alqurashi MM
Saudi Med J; 2021 Nov; 42(11):1243-1246. PubMed ID: 34732558
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia.
Mahallawi WH; Alsarani MA; Aljohani RH; Alluhaibi AA; Alamri TH; Ibrahim NA; Mahallawi KH; Khabourd OF
Ann Saudi Med; 2022; 42(2):69-74. PubMed ID: 35380058
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.
Atzl M; Muendlein A; Winder T; Fraunberger P; Brandtner EM; Geiger K; Klausberger M; Duerkop M; Sprenger L; Mutschlechner B; Volgger A; Benda M; Severgnini L; Jaeger JB; Drexel H; Lang A; Leiherer A
BMJ Open; 2022 May; 12(5):e052130. PubMed ID: 35613821
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
[TBL] [Abstract][Full Text] [Related]
18. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Lumley SF; Wei J; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Peck LJ; Ritter TG; de Toledo Z; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Crook DW; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Walker TM; Jeffery K; Eyre DW;
Clin Infect Dis; 2021 Aug; 73(3):e699-e709. PubMed ID: 33400782
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
20. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
